Abstract
This manuscript comments on the problems identified by Dr Yucha in biofeedback efficacy studies in the treatment of hypertension. In general, Dr Yucha's points are well taken. Further considerations, though, are raised with respect to choice of studies, long-term follow-up, confounding factors, and dropouts.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
